Need a cost effective and self-sufficient LV-producing cell line?
White paper
Development and Optimization of In-House Serum Free Suspension-Adapted 293T Cell Line for Lentiviral Vector Production to Improve Cell & Gene Therapy Manufacturing
Learn MoreSecondary Malignancies Following CAR-T Cell Therapy | What Could We Learn from the FDA Investigation?
Need to robustly validate your VCN assay?
Posters
An Efficient Approach to Check the Accuracy of Viral Vector Copy Number by Droplet Digital PCR
Learn MoreWant to improve lentiviral vector yields?
Posters
Exploring Innovative Methods for Enhancing Lentiviral Vector Yield and Target Cell Infectivity in CAR-T Cell Therapy Manufacturing
Learn MoreNeed earlier readouts for your CAR tonic signaling?
Posters
Early Detection of Tonic Signaling in Primary Human CAR-T Cells by Flow Cytometry
Learn MoreReady to switch from adherent to suspension for LV production?
Posters
Development of an In-House Suspension Lentiviral Vector Production Cell Line to Accelerate Manufacture of Cell Therapy Products
Learn More